Cancer Pathogenesis and Therapy
Country
China
Asiatic Region
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Pathology and Forensic Medicine
Q1
└
Histology
Q2
└
Oncology
Q2
Publisher
SJR 2025
0.889
Q1
SJR Score
H-Index
13
Citations / Doc (2yr)
3.87
Total Docs. (latest)
61
Total Citations (3yr)
302
Publication type
Journals
ISSN
29497132, 20972563
Coverage
2023-2026
Journal Rank
#5,882
Subject Categories
Pathology and Forensic Medicine
Q1
Histology
Q2
Oncology
Q2
Cancer Research
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 61 |
| Total Docs. (3 years) | 78 |
| Total Refs. | 4,014 |
| Total Citations (3 years) | 302 |
| Citable Docs. (3 years) | 74 |
| Citations / Doc. (2 years) | 3.87 |
| Ref. / Doc. | 65.80 |
| % Female | 36.4% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Cancer Pathogenesis and Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Cancer Pathogenesis and Therapy has an SJR of 0.889 and is ranked Q1.
What is the SJR and quartile of Cancer Pathogenesis and Therapy?
Cancer Pathogenesis and Therapy has an SJR (SCImago Journal Rank) of 0.889 and its best quartile is Q1.
What is the H-index of Cancer Pathogenesis and Therapy?
The H-index of Cancer Pathogenesis and Therapy is 13, meaning 13 of its articles have each been cited at least 13 times.
Is Cancer Pathogenesis and Therapy indexed in Scopus?
Yes. Cancer Pathogenesis and Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.